Skip to search formSkip to main contentSkip to account menu

Platelet Factor 4

Known as: platelet factor IV, gamma Thromboglobulin, Heparin Neutralizing Protein 
A CXC chemokine that is found in the alpha granules of PLATELETS. The protein has a molecular size of 7800 kDa and can occur as a monomer, a dimer or… 
National Institutes of Health

Related topics

Related topics

25 relations

Broader (3)

Blood Coagulation FactorCoagulantsProteoglycan
In BloodPF4 genePF4 wt AllelePF4V1 gene

Narrower (3)

Platelet Factor 4, humanRecombinant Platelet Factor 4platelet factor 4 (59-70)

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2009
2009
Platelet factor 4 (PF-4). An electroimmuno assay for PF-4 in human plasma.
An immunological method for the quantitation of platelet factor 4 (PF-4) in human plasma and serum is reported. Purified human… 
2009
2009
Plasma levels of platelet factor 4 in patients admitted to a coronary care unit.
Blood was obtained from 63 consecutive patients within 24 h period after the admission to a coronary care unit for the… 
1998
1998
Prevalence of Heparin-Induced PF4-Heparin Antibodies in Hemodialysis Patients
This article is also accessible online at: http://BioMedNet.com/karger Dear Sir, Heparin-induced thrombocytopenia (HIT… 
Highly Cited
1985
Highly Cited
1985
An Objective Assessment of the Interaction of Heparin and Its Fractions with Human Platelets
We have shown that heparin and heparin fractions cause in vitro platelet aggregation in a large portion of a normal population… 
1985
1985
Platelet factor 4 release induced by intravenous administration of heparin.
When heparin is injected intravenously, it can induce an immediate release of platelet factor 4 PF4), probably from the non… 
1985
1985
Inhibition of human neutrophil receptor-mediated uptake of N-formyl-met-leu-phe by platelet factor 4 (59-70).
Human platelet factor 4 (PF4) and a substituent dodecapeptide designated PF4(59-70) elicited human neutrophil and monocyte… 
1984
1984
Objective assessment of heparin requirements for hemodialysis in humans.
The abilities of four heparin regimens to inhibit activation of blood coagulation, fibrinolysis, and the platelet release… 
1983
1983
Recent progress in the role of platelets in occlusive vascular disease.
Abstract not available. 
1982
1982
Activation of platelets in patients with chronic proliferative glomerulonephritis and the nephrotic syndrome.
Platelet count, volume and aggregation and plasma levels of beta-thromboglobulin (beta-TG) and platelet factor 4 (PF-4) were… 
1978
1978
Interaction of human platelets with heparinized agarose gel.
Platelet interaction with surfaces to which heparin had been covalently bonded was investigated with a chromatographic technique…